Adipokines: inflammation and the pleiotropic role of white adipose tissue

British Journal of Nutrition - Tập 92 Số 3 - Trang 347-355 - 2004
Paul Trayhurn1, I. Stuart Wood1
1Neuroendocrine and Obesity Biology Unit, Liverpool Centre for Nutritional Genomics, School of Clinical Sciences, University of Liverpool, Daulby Street, Liverpool L69 3GA, UK

Tóm tắt

White adipose tissue is now recognised to be a multifunctional organ; in addition to the central role of lipid storage, it has a major endocrine function secreting several hormones, notably leptin and adiponectin, and a diverse range of other protein factors. These various protein signals have been given the collective name ‘adipocytokines’ or ‘adipokines’. However, since most are neither ‘cytokines’ nor ‘cytokine-like’, it is recommended that the term ‘adipokine’ be universally adopted to describe a protein that is secreted from (and synthesised by) adipocytes. It is suggested that the term is restricted to proteins secreted from adipocytes, excluding signals released only by the other cell types (such as macrophages) in adipose tissue. Theadipokinome(which together with lipid moieties released, such as fatty acids and prostaglandins, constitute thesecretomeof fat cells) includes proteins involved in lipid metabolism, insulin sensitivity, the alternative complement system, vascular haemostasis, blood pressure regulation and angiogenesis, as well as the regulation of energy balance. In addition, there is a growing list of adipokines involved in inflammation (TNFα, IL-1β, IL-6, IL-8, IL-10, transforming growth factor-β, nerve growth factor) and the acute-phase response (plasminogen activator inhibitor-1, haptoglobin, serum amyloid A). Production of these proteins by adipose tissue is increased in obesity, and raised circulating levels of several acute-phase proteins and inflammatory cytokines has led to the view that the obese are characterised by a state of chronic low-grade inflammation, and that this links causally to insulin resistance and the metabolic syndrome. It is, however, unclear as to the extent to which adipose tissue contributes quantitatively to the elevated circulating levels of these factors in obesity and whether there is a generalised or local state of inflammation. The parsimonious view is that the increased production of inflammatory cytokines and acute-phase proteins by adipose tissue in obesity relates primarily to localised events within the expanding fat depots. It is suggested that these events reflect hypoxia in parts of the growing adipose tissue mass in advance of angiogenesis, and involve the key controller of the cellular response to hypoxia, the transcription factor hypoxia inducible factor-1.

Từ khóa


Tài liệu tham khảo

10.1016/S0021-9150(98)00281-0

10.1126/science.7678183

10.1007/s001090100198

10.1038/sj.ijo.0801792

10.1038/sj.ijo.0802502

10.1038/382250a0

10.1161/01.CIR.100.25.2473

Klaus, 2004, Adipose tissue as a regulator of energy balance, Curr Drug Targets, 4, 1

Mohamed-Ali, 1997, Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo, J Clin Endocrinol Metab, 82, 4196

10.1038/90984

10.1079/PNS200194

10.2337/diab.46.12.1939

Peeraully, 2004, NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines, Am J Physiol, 287

10.1079/PNS200199

10.1073/pnas.162349799

10.1038/sj.ijo.0802494

10.1016/S0021-9150(01)00488-9

10.1161/01.CIR.93.1.106

10.1074/jbc.M107101200

10.1126/science.3299705

10.1128/MCB.20.14.5343-5349.2000

10.1016/j.bbrc.2003.12.008

10.1016/S0899-9007(01)00672-4

10.1210/jcem.87.8.8781

10.1056/NEJM199902113400607

10.1007/s001250050868

Hasan, 2000, Coordinate expression of NGF and alpha-smooth muscle actin mRNA and protein in cutaneous wound tissue of developing and adult rats, Cell Tissue Res, 300, 97

10.2337/diabetes.52.8.2097

10.2337/diabetes.52.4.942

10.1073/pnas.2336140100

10.1016/S0006-291X(02)02843-7

10.1055/s-2007-978682

10.1172/JCI118404

10.1074/jbc.M004029200

10.1016/S0166-2236(96)10058-8

10.1038/oby.2001.54

Claffey, 1992, Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways, J Biol Chem, 267, 16317, 10.1016/S0021-9258(18)42003-0

Frühbeck, 2001, The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation, Am J Physiol, 280, E827

10.1161/01.ATV.20.6.1595

10.1006/bbrc.1999.0255

10.2337/diabetes.51.8.2369

10.1073/pnas.82.19.6480

10.1161/01.CIR.0000055188.83694.B3

Soukas, 2000, Leptin-specific patterns of gene expression in white adipose tissue, Genes Dev, 14, 963, 10.1101/gad.14.8.963

10.2337/diabetes.49.8.1374

Yokota, 2000, Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages, Blood, 96, 1723, 10.1182/blood.V96.5.1723

Höpfl, 2004, HIFs and tumors - causes and consequences, Am J Physiol, 286, R608

10.2169/internalmedicine.38.202

10.1038/90992

10.1074/jbc.M205172200

Binley, 2003, Exploiting the hypoxia response, Curr Opin Mol Ther, 5, 650

Bastard, 2000, Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss, J Clin Endocrinol Metab, 85, 3338

10.1038/oby.2003.74

10.1161/hc0502.103331

10.1677/joe.0.180R001

10.1002/jcp.10061

10.1038/sj.ijo.0800770

10.1042/bj2650621

10.1001/jama.282.22.2131

10.1096/fj.01-0944rev

10.1161/01.ATV.19.4.972

10.1172/JCI200319246

10.1016/S0955-0674(00)00194-0

10.1172/JCI200319451

10.1079/PNS2001110

Bruun, 2001, Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro, J Clin Endocrinol Metab, 86, 1267

10.1210/en.2003-0580

10.1038/sj.ijo.0802499

10.1210/en.2003-1336

10.1210/jc.2002-021437

10.1046/j.1432-1327.1999.00657.x

10.4049/jimmunol.169.2.642

Hellwig-Bürgel, 1999, Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1, Blood, 94, 1561, 10.1182/blood.V94.5.1561

10.1210/jc.2002-020135

10.1074/mcp.M200006-MCP200

10.1016/S0021-9150(99)00463-3

10.1046/j.1469-7580.2003.00203.x

10.1038/sj.ijo.0802407

10.1016/S0161-5890(01)00042-6

10.1006/bbrc.1995.1496

10.1038/372425a0

10.1038/sj.ijo.0801719

10.1016/S0006-291X(02)00230-9

10.1194/jlr.M300406-JLR200

10.1038/sj.ijo.0802496

Thông tin
Thông tin xuất bản

British Journal of Nutrition

Tập 92 Số 3

347-355

Thông tin tác giả